Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
SXTC: China SXT Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
SXTC
The Story
SXTC
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
-9.7% / yr
Operating margin
-336.5%
ROIC
-23.3%
Financially safe
Stretched
Debt / equity
0.04×
Interest coverage
-28.9×
Current ratio
7.93×
China SXT Pharmaceuticals, Inc.
SXTC
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
China SXT Pharmaceuticals, Inc.
SXTC
NASDAQ
·
USD
·
Closed
$0.06
−15.46%
$0.06
−$0.01 (15.46%)
52W Range
0th
pctl
Volume
2.52×
avg
Mkt Cap
42014
USD
P/E
-0.0
TTM
Div Yield
–
ann
52W Range
0th
pctl
Volume
2.52×
avg
Market Cap
42014
USD
P/E Ratio
-0.0
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings